Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors | Nature Communications
IJMS | Free Full-Text | Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
CD73 is downregulated on CD8 T cells in patients with newly diagnosed... | Download Scientific Diagram
Frontiers | Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
Frontiers | Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma
Downregulation of CD73 associates with T cell exhaustion in AML patients | Journal of Hematology & Oncology | Full Text
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation | SpringerLink
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint | Nature Communications
Frontiers | Application of High-Throughput Imaging Mass Cytometry Hyperion in Cancer Research
Single Cell Spatial Analysis Reveals the Topology of Immunomodulatory Purinergic Signaling in Glioblastoma | bioRxiv
B-hCD73 mice - Biocytogen
![Recombinant Anti-Ezrin antibody [EP886Y] - Plasma Membrane Marker KO Tested (ab40839)](https://www.abcam.com/ps/products/40/ab40839/Images/ab40839-296576-anti-ezrin-antibody-ep886y-western-blot.jpg "Recombinant Anti-Ezrin antibody [EP886Y] - Plasma Membrane Marker KO Tested (ab40839)")
Recombinant Anti-Ezrin antibody [EP886Y] - Plasma Membrane Marker KO Tested (ab40839)
The distinct role of CD73 in the progression of pancreatic cancer | SpringerLink
Frontiers | Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
Downregulation of CD73 associates with T cell exhaustion in AML patients | Journal of Hematology & Oncology | Full Text
CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy | Nature Communications
Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells | Signal Transduction and Targeted Therapy
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint | Nature Communications
Cancers | Free Full-Text | CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39 | Journal of Medicinal Chemistry
Biomarkers Testing for Bladder Cancer - Enzo Life Sciences
